1. AHRO : Austin Health Research Online

Thomas John

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Thomas John
Full Name
John, Thomas
 
Variants
John, Tom
 
Department
 
Personal Site
https://www.onjcancercentre.org/profile/a-prof.-tom-john
 
ORCID
Loading... 3 0 20 0 false

Publications

Results 41-60 of 112 (Search time: 0.018 seconds).

Publication YearTitleAuthor(s)
41Mar-2020Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief Report.Gunjur, Ashray ; Chong, Geoffrey ; Lim, Adeline ; Lau, Eddie ; Mitchell, Paul L R ; John, Thomas ; Arulananda, Surein
42Feb-2020Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.Doebele, Robert C; Drilon, Alexander; Paz-Ares, Luis; Siena, Salvatore; Shaw, Alice T; Farago, Anna F; Blakely, Collin M; Seto, Takashi; Cho, Byung Chul; Tosi, Diego; Besse, Benjamin; Chawla, Sant P; Bazhenova, Lyudmila; Krauss, John C; Chae, Young Kwang; Barve, Minal; Garrido-Laguna, Ignacio; Liu, Stephen V; Conkling, Paul; John, Thomas ; Fakih, Marwan; Sigal, Darren; Loong, Herbert H; Buchschacher, Gary L; Garrido, Pilar; Nieva, Jorge; Steuer, Conor; Overbeck, Tobias R; Bowles, Daniel W; Fox, Elizabeth; Riehl, Todd; Chow-Maneval, Edna; Simmons, Brian; Cui, Na; Johnson, Ann; Eng, Susan; Wilson, Timothy R; Demetri, George D
43Feb-2020Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.Drilon, Alexander; Siena, Salvatore; Dziadziuszko, Rafal; Barlesi, Fabrice; Krebs, Matthew G; Shaw, Alice T; de Braud, Filippo; Rolfo, Christian; Ahn, Myung-Ju; Wolf, Jürgen; Seto, Takashi; Cho, Byoung Chul; Patel, Manish R; Chiu, Chao-Hua; John, Thomas ; Goto, Koichi; Karapetis, Christos S; Arkenau, Hendrick-Tobias; Kim, Sang-We; Ohe, Yuichiro; Li, Yu-Chung; Chae, Young K; Chung, Christine H; Otterson, Gregory A; Murakami, Haruyasu; Lin, Chia-Chi; Tan, Daniel S W; Prenen, Hans; Riehl, Todd; Chow-Maneval, Edna; Simmons, Brian; Cui, Na; Johnson, Ann; Eng, Susan; Wilson, Timothy R; Doebele, Robert C
4422-Jan-2020A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer.Alexander, Marliese; Pavlakis, Nick; John, Thomas ; O'Connell, Rachel; Kao, Steven; Hughes, Brett G M; Lee, Adrian; Hayes, Sarah A; Howell, Viive M; Clarke, Stephen J; Millward, Michael; Burbury, Kate; Solomon, Benjamin; Itchins, Malinda
45Jan-2020Gefitinib and Pemetrexed Improve Survival in EGFR-Mutated NSCLC - Tarring all Patients With the Same Brush?Arulananda, Surein; John, Thomas 
46Jan-2020Programmed Cell Death Ligand 1 Expression in Untreated EGFR Mutated Advanced NSCLC and Response to Osimertinib Versus Comparator in FLAURA.Brown, Helen; Vansteenkiste, Johan; Nakagawa, Kazuhiko; Cobo, Manuel; John, Thomas ; Barker, Craig; Kohlmann, Alexander; Todd, Alexander; Saggese, Matilde; Chmielecki, Juliann; Markovets, Aleksandra; Scott, Marietta; Ramalingam, Suresh S
472020Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.Ramalingam, Suresh S; Vansteenkiste, Johan; Planchard, David; Cho, Byoung Chul; Gray, Jhanelle E; Ohe, Yuichiro; Zhou, Caicun; Reungwetwattana, Thanyanan; Cheng, Ying; Chewaskulyong, Busyamas; Shah, Riyaz; Cobo, Manuel; Lee, Ki Hyeong; Cheema, Parneet; Tiseo, Marcello; John, Thomas ; Lin, Meng-Chih; Imamura, Fumio; Kurata, Takayasu; Todd, Alexander; Hodge, Rachel; Saggese, Matilde; Rukazenkov, Yuri; Soria, Jean-Charles
48Dec-2019Australian consensus statement for best practice ROS1 testing in advanced non-small cell lung cancer.Pavlakis, Nick; Cooper, Caroline; John, Thomas ; Kao, Steven; Klebe, Sonja; Lee, Chee Khoon; Leong, Trishe Y-M; Millward, Michael; O'Byrne, Ken; Russell, Prudence A; Solomon, Benjamin; Cooper, Wendy A; Fox, Stephen
49Dec-2019RET-rearranged non-small-cell lung cancer and therapeutic implications.Loh, Zoe ; Mitchell, Paul L R ; John, Thomas ; Arulananda, Surein
5018-Oct-2019Ceritinib plus nivolumab in patients with advanced ALK-rearranged non-small-cell lung cancer: results of an open-label, multicenter, phase 1B study: Ceritinib plus nivolumab in ALK-rearranged NSCLC.Felip, Enriqueta; de Braud, Filippo G; Maur, Michela; Loong, Herbert H; Shaw, Alice Tsang; Vansteenkiste, Johan F; John, Thomas ; Liu, Geoffrey; Lolkema, Martijn P; Selvaggi, Giovanni; Giannone, Vanessa; Cazorla, Pilar; Baum, Jason; Balbin, O Alejandro; Wang, Luojun Victor; Lau, Yvonne Y; Scott, Jeffrey W; Shao-Weng Tan, Daniel
519-Oct-2019Brief Report: Programmed Cell Death Ligand 1 Expression in Untreated EGFR Mutated Advanced Non-Small Cell Lung Cancer and Response to Osimertinib versus Comparator in FLAURA.Brown, Helen; Vansteenkiste, Johan; Nakagawa, Kazuhiko; Cobo, Manuel; John, Thomas ; Barker, Craig; Kohlmann, Alexander; Todd, Alexander; Saggese, Matilde; Chmielecki, Juliann; Markovets, Aleksandra; Scott, Marietta; Ramalingam, Suresh S
52Sep-2019DDR Alterations as a Surrogate Marker for TMB in SCLC - Use it or Lose it?Arulananda, Surein; Mitchell, Paul L R ; John, Thomas 
53May-2019Standard dose osimertinib for erlotinib refractory T790M-negative EGFR-mutant non-small cell lung cancer with leptomeningeal disease.Arulananda, Surein; Do, Hongdo; Rivalland, Gareth; Loh, Zoe ; Musafer, Ashan; Lau, Eddie ; Mitchell, Paul; Dobrovic, Alexander ; John, Thomas 
5424-Apr-2019BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival.Lee, Erinna F; Harris, Tiffany J ; Tran, Sharon; Evangelista, Marco; Arulananda, Surein; John, Thomas ; Ramnac, Celeste; Hobbs, Chloe; Zhu, Haoran; Gunasingh, Gency; Segal, David; Behren, Andreas; Cebon, Jonathan S ; Dobrovic, Alexander ; Mariadason, John M ; Strasser, Andreas; Rohrbeck, Leona; Haass, Nikolas K; Herold, Marco J; Fairlie, W Douglas
555-Apr-2019Combined tumor sequencing and case/control analyses of RAD51C in breast cancer.Li, Na; McInerny, Simone; Zethoven, Magnus; Cheasley, Dane; Lim, Belle W X; Rowley, Simone M; Devereux, Lisa; Grewal, Norah; Ahmadloo, Somayeh; Byrne, David; Lee, Jue Er Amanda; Li, Jason; Fox, Stephen B; John, Thomas ; Antill, Yoland; Gorringe, Kylie L; James, Paul A; Campbell, Ian G
56Apr-2019Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort.Rivalland, Gareth; Mitchell, Paul L R ; Murone, Carmel ; Asadi, Khashayer; Morey, Adrienne L; Starmans, Maud; Boutros, Paul C; Walkiewicz, Marzena; Solomon, Benjamin; Wright, Gavin; Knight, Simon; John, Thomas 
57Apr-2019Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001.Paz-Ares, L; Doebele, R C; Farago, A F; Liu, S V; Chawla, S P; Tosi, D; Blakely, C M; Krauss, J C; Sigal, D; Bazhenova, L; John, Thomas ; Besse, B; Wolf, J; Seto, T; Chow-Maneval, E; Ye, C; Simmons, B; Demetri, G D
58Apr-2019Osimertinib as first-line (1L) treatment for epidermal growth factor receptor (EGFR) mutation-positive advanced non-small cell lung cancer (NSCLC): Final efficacy and safety results from two phase I expansion cohorts.Yang, J C-H; Ramalingam, S S; Lee, C K; Kurata, T; Kim, D-W; John, Thomas ; Nogami, N; Ohe, Y; Rukazenkov, Y; Murphy, M; Jänne, P A
59Apr-2019Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2.Barlesi, F; Drilon, A; De Braud, F; Cho, B C; Ahn, M J; Siena, S; Krebs, M G; Lin, C C; John, Thomas ; Tan, D S W; Seto, T; Dziadziuszko, R; Arkenau, H-T; Rolfo, C; Wolf, J; Ye, C; Riehl, T; Eng, S; Doebele, R C
6027-Mar-2019Epidermal growth factor receptor (EGFR)-targeted therapies in Mesothelioma.Chia, Puey Ling ; Scott, Andrew M ; John, Thomas